Two-Hormone 'Pancreas' fights dangerous lows in diabetes

NCT ID NCT06082973

Summary

This study tested two versions of an automated insulin delivery system, often called an artificial pancreas, in 15 adults with type 1 diabetes. Researchers wanted to see if a system that automatically gives both insulin and a hormone called glucagon works better at preventing low blood sugar than a system that only gives insulin and suggests eating carbs. Each participant tried both systems during two separate 12-hour hospital stays that included a meal and unannounced exercise.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hospital Clínico Universitario de Valencia

    Valencia, 46010, Spain

Conditions

Explore the condition pages connected to this study.